Managing Agitation and Psychosis in Dementia
For researchers, advanced learners, and clinical scholars
Schneider LS, et al. Effectiveness of atypical antipsychotic drugs in patients with Alzheimer's disease. N Engl J Med. 2006;355(15):1525-1538.
CATIE-AD trial showing modest efficacy but significant adverse effects, informing the risk-benefit discussion in dementia care.
Kales HC, et al. Management of behavioral symptoms in dementia. JAMA. 2015;314(19):2034-2035.
Seminal paper establishing the DICE (Describe, Investigate, Create, Evaluate) framework as standard of care.
12-item clinician-rated scale for tardive dyskinesia monitoring. Should be administered every 3-6 months for patients on antipsychotics.
Download AIMS FormComprehensive assessment tool for BPSD severity and caregiver distress across 12 domains.
Download NPI25-item scale specifically designed for dementia-related behavioral symptoms.
Download BEHAVE-ADDemonstration of entering the patient's reality and validating emotions rather than correcting misperceptions.
Person-centered techniques for personal care resistance in dementia—reducing conflict during bathing and hygiene activities.
10 additional case vignettes covering:
Patient-friendly materials covering:
Printable clinical tools:
25 assessment questions with detailed rationales covering:
| Topic | Connection to BPSD | Resource |
|---|---|---|
| Delirium Recognition | Differentiating from dementia | 4AT Test, CAM |
| Palliative Care in Dementia | Comfort-focused approaches | ELNEC curriculum |
| Caregiver Support | Reducing burnout, improving outcomes | REACH program |
| Polypharmacy in Elderly | Deprescribing, Beers Criteria | AGS Guidelines |